Cruise ship will be a floating Central Park

Central Park is moving to the ocean -- sort of.

Royal Caribbean Cruises said that an area resembling New York's Central Park will be featured in the center of its Project Genesis ship when it is delivered in late 2009 as the world's largest cruise vessel. Spanning the length of a football field, Central Park will include lush foliage, quiet walkways, restaurants, boutiques, an art gallery and a moving bar.

The area also will feature concerts and street performances, providing the feeling of an outdoor space. The 225,000-gross-ton Project Genesis will carry 5,400 passengers and sail from Port Everglades in Fort Lauderdale, Fla.

WORKPLACE

'Mental health' days common

Feel like you're going crazy? Maybe you need a day off.

More than 80% of employees admit to taking "mental health" days from work to recover or recharge, according to a poll conducted by ComPsych Corp., which provides corporate counseling services.

Almost a third said family and relationship issues were the cause, while 20% cited work-related stress and 12% being tired.

The online survey polled 1,036 employees of ComPsych's company clients.

PHARMACEUTICALS

Antidepressant generic gets OK

A cheaper, generic version of GlaxoSmithKline's Wellbutrin XL antidepressant is just as safe and effective as the original drug, despite complaints from some patients, the Food and Drug Administration said.

The FDA said it received 85 reports from patients who switched from Wellbutrin XL to a cheaper generic by Teva Pharmaceutical Industries and Impax Laboratories Inc., including 78 who said they slipped back into depression.

Agency scientists reviewed versions of the two drugs and found the data did not show the problems stemmed from any differences between them.

Nexium generic delayed till 2014

A lawsuit settlement between AstraZeneca and India's Ranbaxy Laboratories will ensure that a cheap, copycat version of the best-selling heartburn drug Nexium won't hit the market until 2014.

Nexium is the second-biggest prescription medicine globally, with sales of $5.2 billion in 2007. But its future has been under a cloud with the recent expiration of a stay blocking regulatory approval of a generic version.

Under the deal, Ranbaxy can start selling a generic version of Nexium in May 2014.

RECALLS